464 related articles for article (PubMed ID: 12205190)
21. Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.
Satoh Y; Hirashima N; Tokumaru H; Takahashi MP; Kang J; Viglione MP; Kim YI; Kirino Y
J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):427-38. PubMed ID: 9508807
[TBL] [Abstract][Full Text] [Related]
22. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
[TBL] [Abstract][Full Text] [Related]
23. Reduced safety factor for neuromuscular transmission and abnormal quantal secretion precede neuromuscular weakness induced by dithiobiuret.
Atchison WD
Toxicol Appl Pharmacol; 1990 Nov; 106(2):234-44. PubMed ID: 2175053
[TBL] [Abstract][Full Text] [Related]
24. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.
Vincent A; Lang B; Newsom-Davis J
Trends Neurosci; 1989 Dec; 12(12):496-502. PubMed ID: 2480664
[TBL] [Abstract][Full Text] [Related]
25. Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist.
Tarr TB; Lacomis D; Reddel SW; Liang M; Valdomir G; Frasso M; Wipf P; Meriney SD
J Physiol; 2014 Aug; 592(16):3687-96. PubMed ID: 25015919
[TBL] [Abstract][Full Text] [Related]
26. Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya.
Kaja S; van de Ven RC; van Dijk JG; Verschuuren JJ; Arahata K; Frants RR; Ferrari MD; van den Maagdenberg AM; Plomp JJ
Eur J Neurosci; 2007 Apr; 25(7):2009-20. PubMed ID: 17439489
[TBL] [Abstract][Full Text] [Related]
27. Calcium channels coupled to neurotransmitter release at neonatal rat neuromuscular junctions.
Rosato Siri MD; Uchitel OD
J Physiol; 1999 Jan; 514 ( Pt 2)(Pt 2):533-40. PubMed ID: 9852333
[TBL] [Abstract][Full Text] [Related]
28. Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads.
Meriney SD; Tarr TB; Ojala KS; Wu M; Li Y; Lacomis D; Garcia-Ocaña A; Liang M; Valdomir G; Wipf P
Ann N Y Acad Sci; 2018 Jan; 1412(1):73-81. PubMed ID: 29125190
[TBL] [Abstract][Full Text] [Related]
29. Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome.
Chaudhry V; Watson DF; Bird SJ; Cornblath DR
Muscle Nerve; 1991 Dec; 14(12):1227-30. PubMed ID: 1662773
[TBL] [Abstract][Full Text] [Related]
30. Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction.
Silinsky EM
J Physiol; 2004 Jul; 558(Pt 2):389-401. PubMed ID: 15146054
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome.
Takamori M; Komai K; Iwasa K
Am J Med Sci; 2000 Apr; 319(4):204-8. PubMed ID: 10768604
[TBL] [Abstract][Full Text] [Related]
32. [Lambert-Eaton myasthenic syndrome (LEMS)].
Suzuki S
Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
[TBL] [Abstract][Full Text] [Related]
33. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.
Plomp JJ; van Kempen GT; Molenaar PC
J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):125-36. PubMed ID: 7965828
[TBL] [Abstract][Full Text] [Related]
34. Age-dependent contribution of P/Q- and R-type Ca2+ channels to neuromuscular transmission in lethargic mice.
Molina-Campos E; Xu Y; Atchison WD
J Pharmacol Exp Ther; 2015 Feb; 352(2):395-404. PubMed ID: 25472955
[TBL] [Abstract][Full Text] [Related]
35. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
36. Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Springer Semin Immunopathol; 1985; 8(1-2):129-40. PubMed ID: 2988146
[TBL] [Abstract][Full Text] [Related]
37. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
Peers C; Lang B; Newsom-Davis J; Wray DW
J Physiol; 1990 Feb; 421():293-308. PubMed ID: 2161458
[TBL] [Abstract][Full Text] [Related]
38. Ca2+ channels and synaptic transmission at the adult, neonatal, and P/Q-type deficient neuromuscular junction.
Nudler S; Piriz J; Urbano FJ; Rosato-Siri MD; Renteria ES; Uchitel OD
Ann N Y Acad Sci; 2003 Sep; 998():11-7. PubMed ID: 14592858
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
40. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
